Does prehabilitation modify muscle mass in patients with rectal cancer undergoing neoadjuvant therapy? A subanalysis from the REx randomised controlled trial

BACKGROUND: Patients with rectal cancer who present with sarcopenia (low muscle mass) are at significantly greater risk of postoperative complications and reduction in disease-free survival. We performed a subanalysis of a randomised controlled study [the REx trial; www.isrctn.com; 62859294] to asse...

Descripción completa

Detalles Bibliográficos
Autores principales: Moug, S. J., Barry, S. J. E., Maguire, S., Johns, N., Dolan, D., Steele, R. J. C., Buchan, C., Mackay, G., Anderson, A. S., Mutrie, N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7429543/
https://www.ncbi.nlm.nih.gov/pubmed/32564236
http://dx.doi.org/10.1007/s10151-020-02262-1

Ejemplares similares

Ejemplares similares